MedTrace Logo

Breast Tumor Oxygenation During Exercise

NCT02340468 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-11-01

No results posted yet for this study

Summary

In the field of cancer treatment, it is generally accepted that the enhancement of oxygen delivery to tumors can augment the effect of anti-cancer therapies. In the case of chemotherapy, this enhancement might lead to a larger amount of a given dose of treatment reaching the tumor and having an effect.

Conditions

  • Breast Tumor

Interventions

DEVICE

diffuse optical spectroscopy

diffuse optical spectroscopy

Sponsors & Collaborators

  • Beckman Laser Institute University of California Irvine

    collaborator OTHER

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Bruce Tromberg, PhD · Beckman Laser Institute

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2018-01-31
Completion
2018-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02340468 on ClinicalTrials.gov